2050-25-1

Basic information

• Product Name: 2-[2-(BENZYLOXY)ETHOXY]ETHANOL
• Synonyms: 2-[2-(BENZYLOXY)ETHOXY]ETHANOL;DI(ETHYLENE GLYCOL) BENZYL ETHER;DIETHYLENE GLYCOL MONOBENZYL ETHER;2-[2-(phenylmethoxy)ethoxy]-Ethanol;5-(Benzyloxy)-3-oxapentane-1-ol;Benzyl-PEG3-alcohol;Benzyl-PEG2-alcohol;Di(ethylene glycol) benzyl ether 97%
• CAS NO: 2050-25-1
• Molecular Formula: C₁₁H₁₆O₃
• Molecular Weight: 196.24
• Mol File: 2050-25-1.mol
• Article Data: 25

Chemical Properties

• Boiling Point: 80-110 °C0.5 mm Hg(lit.)
• Flash Point: >230 °F
• Appearance: /
• Density: 1.094 g/mL at 25 °C(lit.)
• Vapor Pressure: 0.000245mmHg at 25°C
• Refractive Index: n20/D 1.51(lit.)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 14.36±0.10(Predicted)
• Water Solubility: Soluble in water
• CAS DataBase Reference: 2-[2-(BENZYLOXY)ETHOXY]ETHANOL(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[2-(BENZYLOXY)ETHOXY]ETHANOL(2050-25-1)
• EPA Substance Registry System: 2-[2-(BENZYLOXY)ETHOXY]ETHANOL(2050-25-1)

Safety Data

• Safety Statements: 24/25
• WGK Germany: 3
• Hazardous Substances Data: 2050-25-1(Hazardous Substances Data)

Usage

Description

Benzyl-PEG3-alcohol is a PEG linker with an acid labile, benzyl protecting group and a reactive primary alcohol. The primary alcohol can react and further derivatize the compound. The hydrophilic PEG linker increases the water solubility of the compound in aqueous media.

Chemical Properties

Colorless to light yellow liquid

Uses

Di(ethylene glycol) benzyl ether may be used as an initiator in the preparation of linear-PLA (poly(L-lactide).

InChI:InChI=1/C11H16O3/c12-6-7-13-8-9-14-10-11-4-2-1-3-5-11/h1-5,12H,6-10H2

Upstream product

• 100-44-7 benzyl chloride 
• 111-46-6 diethylene glycol 
• 622-08-2 2-Benzyloxyethanol 
• 107-07-3 2-chloro-ethanol 
• 100-39-0 benzyl bromide 
• 75-21-8 oxirane 
• 100-51-6 benzyl alcohol 
• 17229-17-3 benzyl 2-chloroethyl ether 
• 7388-28-5 sodium 2-hydroxyethoxide 

Downstream Products

• 6913-77-5 2-Butyloxymethoxy-2'-benzyloxy-diethylether 
• 91842-53-4 10-phenyl-3,6,9-trioxadecanoic acid 
• 159526-75-7 (2S)-(+)-methyl 2-(N-benzyloxycarbonylamino)-9-benzyloxy-4,7-dioxanonanoate 
• 6875-83-8 di(ethylene glycol) benzyl methoxymethyl ether 
• 98627-23-7 13-[2-(2-Benzyloxy-ethoxy)-ethyl]-5-benzyloxymethyl-1,4,7,10-tetraoxa-13-aza-cyclopentadecane 
• 869310-52-1 (2-benzyloxy-ethoxy)-acetaldehyde 
• 1262964-31-7 ((2-(2-fluoroethoxy)ethoxy)methyl)benzene 
• 1443300-55-7 tert-butyl 3-(2-(2-(benzyloxy)ethoxy)ethoxy)-2,2-dimethylpropanoate 
• 150272-33-6 di(ethylene glycol)monobenzyl ether methanesulfonate 
• 81731-01-3 benzyloxyethoxyethyl chloroformate 
• 98627-22-6 2-<2-(phenylmethoxy)ethoxy>ethanol 4-methylbenzenesulfonate 
• 127457-61-8 3-[2-(2-Benzyloxy-ethoxy)-ethoxy]-propionic acid methyl ester 
• 86520-56-1 methyl 10-phenyl-3,6,9-trioxadecanoate 
• 93206-09-8 <2-(benzyloxy)ethoxy>acetic acid 

Relevant articles and documents

Antibody drug conjugate, intermediate, preparation method, pharmaceutical composition and uses thereof

Disclosed are an antibody drug conjugate IB, which uses ether linkages for connection, and improves the water solubility, stability and cytotoxicity in vivo and in intro, and an intermediate, a pharmaceutical composition, and uses of the antibody drug conjugate. The antibody drug conjugate has simple synthetic steps and a high yield.

Aryl substituted phosphorothio amine derivatives and their use in medical application

The invention relates to an aryl-substituted phosphonaminate and an application of the aryl-substituted phosphonaminate in medical science, in particular to an aryl-substituted phosphonaminate showed in a general formula (I), stereoisomer of the aryl-subs

8034

Abstract A series of arabinose glycosyl sulfamides with varying alkyl chain types and lengths were synthesised as mimics of decaprenolphosphoarabinose (DPA), and as potential inhibitors of mycobacterial cell wall biosynthesis. Unprecedented conversion of